Stock Analysis

3 US Undiscovered Gems With Strong Potential

NasdaqGM:IRMD
Source: Shutterstock

The United States market has shown positive momentum, rising 1.7% over the last week and climbing 12% in the past year, with earnings projected to grow by 15% annually in the coming years. In this environment, identifying undiscovered stocks with strong potential can provide unique opportunities for investors looking to capitalize on emerging growth stories.

Advertisement

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
West Bancorporation169.96%-1.41%-8.52%★★★★★★
Oakworth Capital42.08%15.43%7.31%★★★★★★
FineMark Holdings122.25%2.34%-26.34%★★★★★★
Metalpha Technology HoldingNA81.88%-4.97%★★★★★★
Senstar TechnologiesNA-20.82%14.32%★★★★★★
Valhi43.01%1.55%-2.64%★★★★★☆
China SXT Pharmaceuticals64.25%-29.05%10.33%★★★★★☆
Gulf Island Fabrication19.65%-2.17%42.26%★★★★★☆
Pure Cycle5.11%1.07%-4.05%★★★★★☆
Solesence82.42%23.41%-1.04%★★★★☆☆

Click here to see the full list of 284 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

Underneath we present a selection of stocks filtered out by our screen.

IRADIMED (IRMD)

Simply Wall St Value Rating: ★★★★★★

Overview: IRADIMED CORPORATION develops, manufactures, markets, and distributes MRI-compatible medical devices and related accessories, disposables, and services in the United States and internationally with a market cap of $769.01 million.

Operations: The company generates revenue primarily from its patient monitoring equipment segment, which contributed $75.15 million. It has a market cap of $769.01 million.

IRADIMED, a nimble player in the medical equipment sector, is making waves with its innovative MRidium® 3870 IV Infusion Pump. The company is debt-free and boasts high-quality earnings, with a notable annual growth rate of 30.8% over the past five years. Trading at 32.6% below fair value estimates, IRADIMED's recent FDA clearance for its new pump underscores its leadership in MRI-compatible devices. With revenue forecasted to grow by 12.8% annually over the next three years, IRADIMED's focus on expanding domestic sales could offset potential challenges from international markets and capital expenditures impacting cash flow and margins.

IRMD Debt to Equity as at Jun 2025
IRMD Debt to Equity as at Jun 2025

Great Southern Bancorp (GSBC)

Simply Wall St Value Rating: ★★★★★★

Overview: Great Southern Bancorp, Inc. is a bank holding company for Great Southern Bank, offering various financial services across the United States with a market capitalization of $667.89 million.

Operations: GSBC generates revenue primarily through its banking operations, amounting to $219.57 million. The company's net profit margin is a key financial indicator for assessing profitability.

With total assets of US$6 billion and equity standing at US$613.3 million, Great Southern Bancorp is a financial entity with a strong footing. Its deposits total US$4.8 billion, closely matched by loans of US$4.7 billion, supported by a net interest margin of 3.4%. The company showcases prudent risk management with customer deposits comprising 88% of its liabilities and an allowance for bad loans at 1858%, well above the industry standard. Additionally, it has repurchased over 730,000 shares for nearly US$38 million this year alone, reflecting confidence in its valuation despite trading below fair value estimates by around 57%.

GSBC Earnings and Revenue Growth as at Jun 2025
GSBC Earnings and Revenue Growth as at Jun 2025

Donnelley Financial Solutions (DFIN)

Simply Wall St Value Rating: ★★★★★☆

Overview: Donnelley Financial Solutions, Inc. offers innovative software and technology-enabled financial regulatory and compliance solutions across the United States, Asia, Europe, Canada, and internationally with a market capitalization of approximately $1.69 billion.

Operations: DFIN generates revenue through four key segments: Capital Markets - Software Solutions ($212.50 million), Investment Companies - Software Solutions ($121.50 million), Capital Markets - Compliance and Communications Management ($314.50 million), and Investment Companies - Compliance and Communications Management ($131.10 million).

Donnelley Financial Solutions, with a focus on software and compliance products, is making strides in the capital markets sector. The company has reduced its debt to equity ratio from 126% to 45.1% over five years, though it remains high at 41.3%. Despite facing negative earnings growth of -9.6%, DFIN's EBIT covers interest payments well (11.7x). Recent share repurchases amounted to $101 million for 6.25% of shares, signaling confidence in its future prospects. With revenue projected to grow by 2.7% annually and margins expected to rise from 11.6% to 14.9%, DFIN seems poised for steady progress amidst market challenges.

DFIN Earnings and Revenue Growth as at Jun 2025
DFIN Earnings and Revenue Growth as at Jun 2025

Seize The Opportunity

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com